Stay updated on SAGE-217 for MDD Relapse Prevention Clinical Trial

Sign up to get notified when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAGE-217 for MDD Relapse Prevention Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T22:22:33.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T22:20:17.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    A new platform revision entry v3.7.0 was added to the record history, replacing the previous v3.6.6. This indicates an update to the versioning or UI of the history log.
    Difference
    0.1%
    Check dated 2026-09-20T22:31:04.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    - The record history now shows the latest release entry (v3.6.6) replacing v3.6.5, reflecting an update to the page's version history.
    Difference
    0.1%
    Check dated 2026-08-30T15:53:58.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The history now shows a new entry: Revision: v3.6.5, replacing v3.6.4. This indicates a minor update to the page's version history rather than a change to the trial data.
    Difference
    0.1%
    Check dated 2026-08-09T11:22:59.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    An entry for revision v3.6.4 was added to the study's record history. The prior revision entry v3.6.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-07-25T17:58:48.000Z thumbnail image

Stay in the know with updates to SAGE-217 for MDD Relapse Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.